title: Antigen-specific human polyclonal antibodies from hyperimmunized cattle.
abstract: Antigen-specific human polyclonal antibodies (hpAbs), produced by hyperimmunization, could be useful for treating many human diseases. However, yields from available transgenic mice and transchromosomic (Tc) cattle carrying human immunoglobulin loci are too low for therapeutic applications. We report a Tc bovine system that produces large yields of hpAbs. Tc cattle were generated by transferring a human artificial chromosome vector carrying the entire unrearranged, human immunoglobulin heavy (hIGH) and kappa-light (hIGK) chain loci to bovine fibroblasts in which two endogenous bovine IgH chain loci were inactivated. Plasma from the oldest animal contained >2 g/l of hIgG, paired with either human kappa-light chain (up to approximately 650 microg/ml, fully human) or with bovine kappa- or lambda-light chain (chimeric), with a normal hIgG subclass distribution. Hyperimmunization with anthrax protective antigen triggered a hIgG-mediated humoral immune response comprising a high proportion of antigen-specific hIgG. Purified, fully human and chimeric hIgGs were highly active in an in vitro toxin neutralization assay and protective in an in vivo mouse challenge assay.
authors.affiliation: Hematech, Inc, 4401 S. Technology Dr., Sioux Falls, South Dakota 57106, USA. ykuroiwa@hematech.com
authors.forename: Yoshimi
authors.initials: Y
authors.lastname: Kuroiwa
authors.forename: Poothappillai
authors.initials: P
authors.lastname: Kasinathan
authors.forename: Thillainayagen
authors.initials: T
authors.lastname: Sathiyaseelan
authors.forename: Jin-an
authors.initials: JA
authors.lastname: Jiao
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Matsushita
authors.forename: Janaki
authors.initials: J
authors.lastname: Sathiyaseelan
authors.forename: Hua
authors.initials: H
authors.lastname: Wu
authors.forename: Jenny
authors.initials: J
authors.lastname: Mellquist
authors.forename: Melissa
authors.initials: M
authors.lastname: Hammitt
authors.forename: Julie
authors.initials: J
authors.lastname: Koster
authors.forename: Satoru
authors.initials: S
authors.lastname: Kamoda
authors.forename: Katsumi
authors.initials: K
authors.lastname: Tachibana
authors.forename: Isao
authors.initials: I
authors.lastname: Ishida
authors.forename: James M
authors.initials: JM
authors.lastname: Robl
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D000942:Antigens, Bacterial / Q000276:immunology; D001427:Bacterial Toxins / Q000276:immunology; D016466:CHO Cells; D002417:Cattle / Q000235:genetics; D022222:Chromosomes, Artificial, Human / Q000235:genetics; D006224:Cricetinae; D003412:Cricetulus; D055786:Gene Knockout Techniques; D006031:Glycosylation; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D007143:Immunoglobulin Heavy Chains / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D007145:Immunoglobulin kappa-Chains / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D051379:Mice; D009500:Neutralization Tests; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D007074:Immunoglobulin G; D007143:Immunoglobulin Heavy Chains; D007145:Immunoglobulin kappa-Chains; D011993:Recombinant Fusion Proteins; C030325:anthrax toxin